Notice: This company has been marked as potentially delisted and may not be actively trading. FTD Companies (FTD) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Wendy Williams is ‘permanently incapacitated’ amid dementia battle, guardian revealsNovember 28, 2024 | msn.comCervoMed Stock Surges On FDA Orphan Drug Nod For FTD Treatment: Retail Optimism RekindledNovember 27, 2024 | msn.comCervoMed Says FDA Grants Orphan Drug Designation For Neflamapimod In Frontotemporal DementiaNovember 27, 2024 | markets.businessinsider.comPassage Bio Advances PBFT02 Gene Therapy Program Amidst Positive Q3 2024 ResultsNovember 15, 2024 | msn.comPassage Bio’s Strong Financial Position and Clinical Progress Justify Buy RatingNovember 15, 2024 | markets.businessinsider.comQuanterix Corporation (NASDAQ:QTRX) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comPassage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business HighlightsNovember 13, 2024 | markets.businessinsider.comGenascence Granted FDA Fast Track Designation for GNSC-001 in Patients with Osteoarthritis (OA) of the KneeNovember 12, 2024 | finance.yahoo.comTransposon to Present Results from Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related ALS/FTD at the 7th Annual ALS ONE Research SymposiumNovember 6, 2024 | finance.yahoo.comCoya Therapeutics: Buying The Dip After Unwarranted Sell-OffOctober 31, 2024 | seekingalpha.comGenelux: 2nd Half Of 2025 PRROC Data Is Major Inflection PointOctober 31, 2024 | seekingalpha.comCisco issues emergency fix for VPN tool, users told to update nowOctober 25, 2024 | msn.comSpinal Muscular Atrophy Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and BarriersOctober 23, 2024 | theglobeandmail.comFPL aims for Sarasota, Manatee counties to have power by ThursdayOctober 12, 2024 | msn.comWe want to make a difference - brothersOctober 7, 2024 | msn.comAnti CD70 Antibodies Clinical Trials FDA Approval CD70 Cancer Therapies Clinical Trials Market Opportunity InsightOctober 5, 2024 | finance.yahoo.combit.bio to Unveil iPSC Advancements and ioCells Toolkit at Society for Neuroscience 2024 Annual ConferenceSeptember 30, 2024 | finance.yahoo.comIntroducing AI Exchange: what does the future hold for the fast-evolving technology?September 27, 2024 | ft.comPublishing Global Industry Almanac 2024: Key Financial Metrics and Analysis of Competitive Pressures 2019-2028September 24, 2024 | finance.yahoo.comFinancière de Tubize SA (FTD.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comQurAlis Announces Expansion of its Selective Kv7.2/7.3 Ion Channel Opener, QRL-101, Into EpilepsySeptember 19, 2024 | sg.finance.yahoo.comPassage Bio Shares Promising Data on PBFT02 for Frontotemporal DementiaSeptember 19, 2024 | msn.comWendy Williams only paid $82K for doc as guardian accuses creators of taking ‘advantage’ of a ‘severely impaired’ person: lawsuitSeptember 18, 2024 | nypost.comPsilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive EffectsSeptember 9, 2024 | benzinga.comSun Pharma and Moebius gain FDA fast track for osteoarthritis drugSeptember 9, 2024 | msn.comDow Jones Futures Rise: Will Apple iPhone 16 Give Bulls A Ring? Palantir, Dell Jump. (Live Coverage)September 9, 2024 | msn.comDow Jones Futures Fall: Will Apple iPhone 16 Give Bulls A Ring? Palantir, Dell Jump (Live Coverage)September 8, 2024 | msn.comDow Jones Futures Due: Apple iPhone 16 Looms, Palantir, Dell Jump, Tesla-xAI In FocusSeptember 8, 2024 | msn.comTD Cowen Sticks to Its Buy Rating for Alector (ALEC)September 7, 2024 | markets.businessinsider.comUSF Research Foundation Proudly Endorses and Invests in Psilera's FTD ResearchSeptember 6, 2024 | finance.yahoo.comVesper Bio reports data from Phase I frontotemporal dementia treatment trialSeptember 5, 2024 | finance.yahoo.comDow Jones Futures: Market Rally At Key Levels; Tesla, Nvidia Are Key MoversSeptember 4, 2024 | msn.comInnovent Gets Fast Track Designation From FDA For IBI363 As Monotherapy For Advanced MelanomaSeptember 4, 2024 | nasdaq.comDow Jones Futures: Record Nvidia Sell-Off Fuels Market Expectations Breaker; What To Do NowSeptember 3, 2024 | msn.comAcuraStem Secures $4 Million in Grant Funding from CIRM to Advance UNC13A Program for ALS and FTDSeptember 3, 2024 | finance.yahoo.comWendy Williams Makes Rare Public Appearance at New Jersey StoreAugust 30, 2024 | msn.comRemeGen Co Ltd (REG.DU)August 29, 2024 | uk.finance.yahoo.comPsilera receives positive preclinical in vivo data for frontotemporal dementia (FTD) candidate, PSIL-006August 27, 2024 | finance.yahoo.comFTD Limited’s Insights: How to Select the Best Liquidity ProviderAugust 22, 2024 | msn.comfabric Expands Executive Team Amidst Strong Company and Customer GrowthAugust 22, 2024 | markets.businessinsider.comQurAlis to Participate in Upcoming Investor and Industry Conferences in SeptemberAugust 21, 2024 | finance.yahoo.comTheriva™ Biologics Reports Second Quarter 2024 Operational Highlights and Financial ResultsAugust 13, 2024 | finance.yahoo.comRegistrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDEAugust 13, 2024 | msn.comBuy Rating Affirmed for Passage Bio on Strong Cost Control and Promising Clinical TrialsAugust 9, 2024 | markets.businessinsider.comYamaha R1 Vs. R1M: What's The Difference Between These Top-Tier Supersport Bikes?August 5, 2024 | msn.comPositive Outlook for Passage Bio: Strategic Financial Moves and Promising Clinical Prospects Boost Buy RatingAugust 3, 2024 | markets.businessinsider.comIntroducing The Warbird AcademyAugust 1, 2024 | msn.comGoldman Sachs Keeps Their Sell Rating on Alector (ALEC)July 25, 2024 | markets.businessinsider.comOS Therapies Announces Positive Safety Data from Phase 1 Clinical Trial of OST-HER2 in HER2-Expressing Breast Cancer and in Preclinical Efficacy in Models of Breast CancerJuly 25, 2024 | businesswire.comPassage Bio targets FDA to greenlight ALS gene therapy trialJuly 25, 2024 | finance.yahoo.com Get FTD Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for FTD and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. FTD Media Mentions By Week FTD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FTD News Sentiment▼0.000.66▲Average Consumer Discretionary News Sentiment FTD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FTD Articles This Week▼02▲FTD Articles Average Week Get FTD Companies News Delivered to You Automatically Sign up to receive the latest news and ratings for FTD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MICS News GPAK News GMBL News HPCO News ELYS News BEDU News SALM News MSC News NFLX News DIS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FTD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FTD Companies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FTD Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
